A Phase I Study Of Continuous Infusion EMD 121974 In Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs Cilengitide (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 21 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 28 Mar 2008 Status changed from recruiting to in progress as reported by ClinincalTrials.gov